Clinical trial
Efficacy of ART to Interrupt HIV Transmission Networks
NCT02528773 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of ART to Interrupt HIV Transmission Networks
- Lead sponsor
- University of California, San Diego
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 9, 2014
- Completion date
- February 14, 2020
- Enrollment
- 256 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv